Koru Medical Systems Inc. (KRMD)
NASDAQ (CM) NASDAQ (CM) Primary 
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
KORU Medical Systems, Inc. ( KRMD ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Linda Tharby - President, CEO & Director Tom Adams - CFO, Secretary & Treasurer Conference Call Participants Louisa Smith - Gilmartin Group LLC Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Joseph Downing - Piper Sandler & Co., Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Greetings, and welcome to KORU Medical Systems Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.
KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Linda M. Tharby - President, CEO & Director Thomas Adams - CFO, Secretary & Treasurer Conference Call Participants Anderson Schock - B.
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KORU Medical Systems, Inc. (KRMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.02 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Louisa Smith - Investor Relations Linda Tharby - Chief Executive Officer and President Tom Adams - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Caitlin Cronin - Canaccord Genuity Chase Knickerbocker - Craig-Hallum Jason Bednar - Piper Sandler Anderson Schock - B. Riley Securities Operator Greetings, and welcome to KORU Medical Systems First Quarter 2025 Earnings Conference Call.
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems Inc. (KRMD) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ET Company Participants Louisa Smith - Investor Relations Linda Tharby - Chief Executive Officer and President Tom Adams - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig Hallum Capital Group Frank Takkinen - Lake Street Capital Markets Jason Bednar - Piper Sandler Anderson Shack - B. Riley Securities Michaela Smith - Canaccord Operator Greetings.
KORU Medical Systems Inc. (KRMD) is a Great Momentum Stock: Should You Buy?
Does KORU Medical Systems Inc. (KRMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
KORU Medical Systems Inc. (KRMD) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.
KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript
KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates
KORU Medical Systems Inc. (KRMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.05 per share a year ago.
